Trials / Completed
CompletedNCT00551694
A Second Study to Determine the Effect of GSK256073A on HVTs
A Second Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single and a Repeat Oral Dose of GSK256073A in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the effects of single and repeat doses of GSK256073 with placebo in HVT subjects that have been administrated GSK256073 in the HMA107787 study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GSK256073A tablets |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2007-10-31
- Last updated
- 2012-06-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00551694. Inclusion in this directory is not an endorsement.